ليست عنوان مقالات لاتين Petrology of two diamondiferous eclogite xenoliths from the Lahtojoki kimberlite pipe, eastern Finland Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Petrology of two diamondiferous eclogite xenoliths from the Lahtojoki kimberlite pipe, eastern Finland

2

Petrology of ultrahigh-pressure eclogites from the ZK703 drillhole in the Donghai, eastern China

3

Petrology of ultramafic lamprophyres from the Beaver Lake area of Eastern Antarctica and their relation to the breakup of Gondwanaland

4

Petrology of ultramafic xenoliths in Cenozoic alkaline rocks of northern Madagascar (Nosy Be Archipelago)

5

Petrology of volcanic products younger than 42 ka on the Lipari–Vulcano complex (Aeolian Islands, Italy): an example of volcanism controlled by tectonics

6

Petrology, geochemistry and genesis of rift-related carbonatites of Ambadungar, India

7

Petrology, geochemistry and geodynamic implications of Jurassic island arc magmatism as revealed by mafic volcanic rocks in the Mesozoic low-grade sequence, eastern Rhodope, Bulgaria

8

Petrology, geochemistry and geodynamic setting of Proterozoic igneous suites of the Orَs fold belt (Borborema Province, Northeast Brazil)

9

Petrology, geochemistry and isotopic ages of eclogites from the Dulan UHPM Terrane, the North Qaidam, NW China

10

Petrology, geochemistry and paleomagnetism of the earliest magmatic rocks of Deccan Volcanic Province, Kutch, Northwest India

11

Petrology, geochemistry and ReOs isotopes of peridotite xenoliths from Maguan, Yunnan Province: Implications for the Cenozoic mantle replacement in southwestern China

12

Petrology, geochemistry and Re–Os isotopes of peridotite xenoliths from Yantai, Shandong Province: Evidence for Phanerozoic lithospheric mantle beneath eastern North China Craton

13

Petrology, geochemistry and Sr–Nd isotopes of the Trindade and Martin Vaz volcanic rocks (Southern Atlantic Ocean)

14

Petrology, geochemistry and Sr–Nd–Pb isotopes of the volcanic rocks from Pico Island—Azores (Portugal)

15

Petrology, geochemistry and tectonic setting intrusive massives of Baft ophiolitic – melange, Southeast of Kerman, Iran

16

Petrology, geochemistry and tectonic significance of Palaeoproterozoic alkaline lamprophyres from the Jungel Valley, Mahakoshal supracrustal belt, Central India

17

PETROLOGY, GEOCHEMISTRY AND TECTONICAL ENVIRONMENT OF THE SHALAIR METAMORPHIC ROCK GROUP AND KATAR RASH VOLCANIC GROUP, SHALAIR VALLY AREA, NORTHEASTERN IRAQ

18

Petrology, Geochemistry and Tectonomagmatic Evolution of Hezar Igneous Complex (Rayen- South of Kerman- Iran): the First Description of an Arc Remnant of the Neotethyan Subduction Zone

19

Petrology, geochemistry and U–Pb geochronology of the Betic Ophiolites: Inferences for Pangaea break-up and birth of the westernmost Tethys Ocean

20

Petrology, geochemistry and zircon U–Pb and Lu–Hf isotopes of the Cretaceous dykes in the central North China Craton: Implications for magma genesis and gold metallogeny

21

Petrology, geochemistry, and geochronology of Paleoproterozoic volcanic and granitic rocks (1.89–1.88 Ga) of the Pitinga Province, Amazonian Craton, Brazil

22

Petrology, geochemistry, and geochronology of the post-collisional Triassic mangerite and syenite in the Gwangcheon area, Hongseong Belt, South Korea

23

Petrology, geochemistry, and geochronology of trondhjemites from the Qori Complex, Neyriz, Iran

24

Petrology, geochemistry, and Na metasomatism of Triassic-Jurassic non-marine clastic sediments in the Newark, Hartford, and Deerfield rift basins, northeastern USA

25

Petrology, geochemistry, and petrogenesis of mafic dykes from the Kermanshah Ophiolite in Sahneh-Harsin area of Western Iran

26

Petrology, Geochemistry, Petrogenesis and Reactivation of Volcanic Tuffs at Dair El-Kahif Area, NE-Jordan

27

Petrology, geochemistry, S, Cl and F abundances, and S oxidation state of sideromelane glass shards from Pleistocene ash layers north and south of Gran Canaria (ODP Leg 157)

28

Petrology, geochronology and Sr–Nd isotopic geochemistry of the Konso pluton, south-western Ethiopia: implications for transition from convergence to extension in the Mozambique Belt

29

Petrology, isotope geochemistry and chemical budgets of oceanic gabbros-seawater interactions in the Equatorial Atlantic

30

Petrology, major and trace element geochemistry, geochronology, and isotopic composition of granitic intrusions from the vicinity of the Bosumtwi impact crater, Ghana

31

Petrology, mineral and isotope geochemistry of the Sondalo gabbroic complex (Central Alps, Northern Italy): implications for the origin of post-Variscan magmatism

32

Petrology, mineral chemistry and Sr–Nd–Pb isotopic compositions of granitoids in the central Menderes metamorphic core complex: Constraints on the evolution of Aegean lithosphere slab

33

Petrology, mineral chemistry, and exploration significance of Fe-sulfides from the metal dispersion halo surrounding the Cadjebut Znsingle bondPb MVT deposit, Western Australia

34

Petrology, Mineralogy and Diagenesis of the Rus and Jil Formations (l- Eocene) in Najif and Samawa areas, Southern Iraq

35

Petrology, mineralogy and geochemistry of oxide minerals in polymict xenoliths from the Bultfontein kimberlites, South Africa: implication for low bulk-rock oxygen isotopic ratios

36

Petrology, Origin and Metamorphic History of Proterozoic-aged Granulites of the Natal Metamorphic Province, Southeastern Africa

37

Petrology, structural setting, timing, and geochemistry of Cretaceous volcanic rocks in eastern Mongolia: Constraints on their tectonic origin

38

Petrology, structure and tectonic significance of the Tuclame banded schists in the Sierras Pampeanas of Cَrdoba and its relationship with the metamorphic basement of northwestern Argentina

39

Petrol—something nasty in the woodshed? A review of gasoline-related burns in a British burns unit

40

Petromagnetic characteristics of Cameroon Line volcanic rocks

41

PETROMAP: MS-DOS software package for quantitative processing of X-ray maps of zoned minerals

42

Petro-mineralogy and geochemistry as tools of provenance analysis on archaeological pottery: Study of Inka Period ceramics from Paria, Bolivia

43

Petronella Clarke

44

Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography

45

Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography

46

Petrophysical analysis of regional-scale thermal properties for improved simulations of geothermal installations and basin-scale heat and fluid flow

47

Petro-physical Analysis of Well Logs for Reservoir Evaluation: A Case Study of Well 1 and 2 of the ‘Ictorian’ Field in the Niger Delta Basin

48

Petrophysical and consolidation behavior of mass transport deposits from the northern Gulf of Mexico, IODP Expedition 308

49

Petrophysical and durability tests on sandstones for the evaluation of their quality as building stones using Analytical Hierarchy Process (AHP)

50

Petrophysical and rock-mechanics effects of CO2 injection for enhanced oil recovery: Experimental study on chalk from South Arne field, North Sea

51

Petrophysical characterization of Chinese coal cores with heat treatment by nuclear magnetic resonance

52

Petrophysical characterization of coals by low-field nuclear magnetic resonance (NMR)

53

Petrophysical Charaterization of the Kwale Field Reservoir Sands (OML 60) from Wire-line Logs, Niger Delta, Nigeria

54

Petrophysical Constraints on Deformation Styles in Aztec Sandstone, Southern Nevada, USA

55

Petrophysical data for integrated flow modeling

56

Petrophysical data prediction from seismic attributes using committee fuzzy inference system

57

Petrophysical databases for ground characterisation: design concepts and considerations

58

Petrophysical Evaluation of Bangestan Group Formations in an Iranian Oil Field Document Type : Research Paper

59

Petrophysical evaluation of low-resistivity sandstone reservoirs with nuclear magnetic resonance log

60

Petrophysical Evaluation of Reservoir in A Selected Well (Z) in an Onshore Oil Field (X) in the Niger Delta Basin, Nigeria using Wireline Logs

61

Petrophysical Evaluation of Reservoir Sand Bodies in Kwe Field Onshore Eastern Niger Delta

62

Petrophysical laboratory measurements for basin and reservoir evaluation

63

Petrophysical Properties and Reservoir Modeling of Mishrif Formation at Amara Oil Field, Southeast Iraq

64

Petrophysical properties of bioclastic platform carbonates: implications for porosity controls during burial

65

Petrophysical properties of porous medium from Petrographic Image Analysis data

66

Petrophysical Properties of the Kahasib Formation in Missan Region, South Iraq

67

Petros D. Karkos, Spiros P. Potamianos, Maria T. Apostolidis, Giorgios Kekes

68

Petrosal approach: The avenue to the cerebellopontine angle and petrous apex

69

Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp Original Research Article

70

Petrosectomies for invasive tumours: surgery and reconstruction

71

Petrosia testudinaria as a biomarker for metal contamination at Gulf of Mannar, southeast coast of India

72

Petrosiols A–E, neurotrophic diyne tetraols isolated from the Okinawan sponge Petrosia strongylata

73

Petrotectonic evolution of the high- to ultrahigh-pressure Maksyutov Complex, Karayanova area, south Ural Mountains: structural and oxygen isotope constraints

74

Petrotetrayndiol A induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells through cytochrome c-mediated activation of caspases

75

Petrous apicitis in a child: computed tomography and magnetic resonance imaging findings

76

Petrov–Galerkin and discontinuous-Galerkin methods for time-domain and frequency-domain electromagnetic simulations

77

Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model

78

Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model

79

Petrov-Galerkin finite element method for gas–liquid two-phase flow based on an incompressible two-fluid model Original Research Article

80

Petrov-Galerkin finite element method for solving the MRLW equation

81

Petrov–Galerkin methods for nonlinear systems without monotonicity Original Research Article

82

PETROV-GALERKIN METHODS FOR THE TRANSIENT ADVECTIVE-DIFFUSIVE EQUATION WITH SHARP GRADIENTS

83

Pets and protein: : placing domestic livestock on hobby-farms in England and Wales

84

PETs and their users: a critical review of the potentials and limitations of the privacy as confidentiality paradigm

85

PETs at CSCL Service: Underutilised Potentials for Privacy Enhancing Distance Education

86

Pets, Maternal Sensitization And Continent Of Ancestry Influence Fetal Ige Production

87

Petschek shocks of reconnection for anisotropic pressure Original Research Article

88

PET-SWNT nanocomposites through ultrasound assisted dissolution-evaporation

89

PET-THERAPY: A TRIAL FOR INSTITUTIONALIZED FRAIL ELDERLY PATIENTS

90

Petua dan Pantang Larang Tradisional dalam Alam Melayu Sarawak

91

Peudoexfoliation and poterior capular opacification

92

Peudoexfoliation in a rural population of outhern India: the Aravind Comprehenive Eye urvey

93

Peudoexfoliation yndrome in Autralian adult

94

Peudohypopyon after intravitreal triamcinolone acetonide injection for cytoid macular edema

95

Peudohypopyon of orange pigment overlying a table choroidal nevu

96

Peudomona aeruginoa in vitro corneal iolate enitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative tudy

97

Peudopapilledema in neurofibromatoi type 2

98

Peumusolide A, unprecedented NES non-antagonistic inhibitor for nuclear export of MEK

99

Peut-on évaluer le rôle de la sédimentation sur lʹeffet de serre à lʹéchelle de temps des cycles orbitaux ?

100

Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?

101

Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?

102

Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?

103

Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?

104

PEUTZ JEGHERS SYNDROME PRESENTING WITH ACUTE INTESTINAL OBSTRUCTION: A RARE CASE REPORT WITH REVIEW OF LITERATURES

105

PEUTZ-JEGHER SYNDROME CASE REPORT AND REVIEW OF LITERATURE

106

Peutz-Jeghers Syndrome With Diffuse Gastrointestinal Polyposis: Three Cases in a Family With Different Manifestations and No Evidence of Malignancy During 14 Years Follow Up

107

Peutz-Jeghers syndrome without mucocutaneous pigmentation: a case report

108

Peutz-Jeghers syndrome: 78-year follow-up of the original family

109

PeV cosmic rays: a window on the leptonic era?

110

PeV gamma rays from interactions of ultra high energy cosmic rays in the Milky Way

111

PeV scale Left–Right symmetry and baryon asymmetry of the Universe Original Research Article

112

Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients

113

Peyer’s patch-mediated intestinal immune system modulating activity of pectic-type polysaccharide from peel of Citrus unshiu

114

Peygamberimiz Hz. Muhammed’in Müezzinleri

115

Peykan check, a simple continuous quality control method for hematology analyzers

116

Peyronie’s disease: A contemporary review of non-surgical treatment

117

Peyssonols A and B, Two Novel Inhibitors of the Reverse Transcriptases of Human Immunodeficiency Virus Types 1 and 2

118

PF. Barlett, Editor, Urban Place: Reconnecting with the Natural World, The MIT Press, Cambridge, MA (2005) ISBN 0-262-52443-0 (330pp., $24.00).

119

PF1022A — A novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues

120

PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation

121

PFA — A component in building materials produced from the german plastic packaging waste stream

122

PFA, a Novel Mollusk Agglutinin, Is Structurally Related to the Ribosome-Inactivating Protein Superfamily

123

Pfaffia mosaic virus: a new potyvirus found infecting Pfaffia glomerata in Brazil

124

Pfaffian and Hafnian identities in shuffle algebras

125

Pfaffian decomposition and a Pfaffian analogue of q-Catalan Hankel determinants

126

Pfaffian ideals of ladders Original Research Article

127

Pfaffian Identities: A Combinatorial Approach

128

Pfaffian representation of solutions to a coupled (2 + 1)-dimensional system

129

Pfaffian solution for coupled discrete nonlinear Schrödinger equation

130

Pfaffian solutions for the Manin-Radul-Mathieu SUSY KdV and SUSY sine-Gordon equations

131

Pfaffianization of a -dimensional generalized Kadomtsev–Petviashvili equation

132

Pfaffianization of the two-dimensional Toda lattice

133

Pfaffians and Determinants for SchurQ-Functions

134

Pfaffians, superpotentials and vector bundle moduli

135

Pfaffʹs method (I): The Mills-Robbins-Rumsey determinant Original Research Article

136

Pfaffʹs method (II): diverse applications

137

PFAM catalyzed enantioselective diethylzinc addition to imines

138

Pfanzagl exchanges diagnose an anomaly in expected utility decision theory Original Research Article

139

PFAPA and 12 Common MEFV Gene Mutations Our Clinical Experience

140

PFC full bridge rectifiers EMI modeling and analysis-common mode disturbance reduction

141

PFC Simulation of Brazilian Tensile Strength Test in Geomaterials’ Specimens with T-shaped Non-persistent Joints

142

PFC: A packet forwarding control scheme for vehicle handover over the ITS networks

143

P-FCM: a proximity—based fuzzy clustering

144

P-FCM: a proximity-based fuzzy clustering for user-centered web applications Original Research Article

145

PFCRT and DHFR-TS Sequences for Monitoring Drug Resistance in Adzopé Area of Côte d’Ivoire After the Withdrawal of Chloroquine and Pyrimethamine

146

Pfcrt Gene in Plasmodium falciparum Field Isolates from Muzaffargarh, Pakistan

147

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective

148

PFEIFFER TYPE I SYNDROME: A GENETICALLY PROVEN CASE REPORT

149

p-FEM applied to finite isotropic hyperelastic bodies Original Research Article

150

p-FEM for finite deformation powder compaction Original Research Article

151

p-FEMs in biomechanics: Bones and arteries

152

PFeW11-doped polymer film modified electrodes and their electrocatalytic activity for H2O2 reduction Original Research Article

153

PFG NMR and internal magnetic field gradients in plant-based materials

154

PFG NMR observation of an extremely strong dependence of the ammonia self-diffusivity on its loading in H-ZSM-5

155

PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands

156

PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands

157

PFG NMR tracer exchange measurements of xenon in zeolites

158

PFGE characterisation and adhesion ability of Listeria monocytogenes isolates obtained from bovine carcasses and beef processing facilities

159

PFGE genotyping and antimicrobial susceptibility of Campylobacter in retail poultry meat in Estonia

160

PFGE genotyping and molecular characterization of Campylobacter spp. isolated from chicken meat

161

PFG-NMR approach to determining the water transport mechanism in polymer electrolyte membranes conditioned at different temperatures

162

PFG-NMR self-diffusion in casein dispersions: Effects of probe size and protein aggregate size

163

PFHC: A clustering algorithm based on data partitioning for unevenly distributed datasets

164

Pfiesteria piscicida and Pfiesteria shumwayae in coastal waters of Long Island, New York, USA

165

Pfiesteria: Harmful Algal Blooms as Indicators of Human: Ecosystem Interactions

166

P-filters and hereditary Baire function spaces

167

P-Filters and the perfect set property

168

p-Filtrations and the Steinberg Module

169

Pfisterʹssubform theorem for reduced special groups

170

Pfizer CEOʹs call to action

171

Pfizer Diflucan Partnership Program

172

Pfizer loses sildenafil case in Australia

173

PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells

174

PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer

175

PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer

176

Pflanzenphysiologie, P. Schopfer, A. Brennicke. Springer Verlag, Berlin, Heidelberg (1999)

177

PF-MPC: Particle filter-model predictive control

178

PfMyb1, a Plasmodium falciparum Transcription Factor, is Required for Intra-erythrocytic Growth and Controls Key Genes for Cell Cycle Regulation Original Research Article

179

PFOS and PFOA in the livers of harbour porpoises (Phocoena phocoena) stranded or bycaught around the UK

180

p-Fractals and power series–I. Some 2 variable results

181

p-Fractals and power series—II.: Some applications to Hilbert–Kunz theory

182

PFS for Mars Express: A new approach to study Martian atmosphere Original Research Article

183

PFS on Mars Express: preparing the analysis of infrared spectra to be measured by the Planetary Fourier Spectrometer

184

PFS/MEX observations of the condensing CO2 south polar cap of Mars

185

PFS: an effective instrument for the study of martian environment Original Research Article

186

PFS-MEX observation of ices in the residual south polar cap of Mars

187

P-functions, Quasi-convex Functions, and Hadamard-type Inequalities1

188

PG 1613+426: A new sdB pulsator

189

PG&E files U.S. suit to halt destec-modesto-praxair deal

190

PG&E proposes its own retail customer accesss

191

PG&E, SCE sell 10,000 MW in plants above book value

192

pg4DB: A fuzzy object-relational system

193

PGA1 and PGA2 are selective ligands for the EP2 and EP4 prostaglandin receptor subtypes

194

PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells

195

PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells

196

PGAMgnam Style: A Glycolytic Switch Controls Biosynthesis

197

PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts

198

PGC1-α mRNA expression cross talk with tumor volume growth and total antioxidant capacity in breast cancer model mice: following discontinuous aerobic exercise and vitamin D intake

199

PGD for aneuploidy screening: an expensive hoax?

200

PGE and Os isotopic analyses of single sample aliquots with NiS fire assay preconcentration

201

PGE and Os-isotopic variations in lavas from Kohala Volcano, Hawaii: Constraints on PGE behavior and melt/crust interaction

202

PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re¯Os and Rb¯Sr isotope study

203

PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re–Os and Rb–Sr isotope study

204

PGE geochemistry and Re–Os dating of massive sulfide ores from the Baimazhai Cu–Ni deposit, Yunnan province, China

205

PGE geochemistry of the Fengshan porphyry–skarn Cu–Mo deposit, Hubei Province, Eastern China

206

PGE mineralization in marginal sulfide ores of the Chineisky layered intrusion, Russia

207

PGE mineralization in the late Archaean iron-rich mafic-ultramafic Hanumalapur Complex, Karnataka, India

208

PGE reefs as an in situ crystallization phenomenon: the Nadezhda gabbronorite body, Lukkulaisvaara layered intrusion, Fennoscandian Shield, Russia

209

PGE Wins Contract to Serve New Palm Springs Muni

210

PGE2 induces oenocytoid cell lysis via a G protein-coupled receptor in the beet armyworm, Spodoptera exigua

211

PGE2 production is suppressed by chemically-synthesized Δ7-eicosatrienoic acid in macrophages through the competitive inhibition of COX-2

212

PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction

213

PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance

214

PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance

215

PGEs and other traffic-related elements in roadside soils from Sa˜o Paulo, Brazil

216

PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity

217

P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil

218

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

219

P-glycoprotein activity in renal clear cell carcinoma

220

P-glycoprotein and sister P-glycoprotein sequences from mummichog, Fundulus heteroclitus, liver and intestine

221

P-Glycoprotein expression by human colonic tumor cells influences the growth of tumor cells in vitro

222

P-glycoprotein expression in human major and minor salivary glands

223

P-glycoprotein expression in Perna viridis after exposure to Prorocentrum lima, a dinoflagellate producing DSP toxins

224

P-glycoprotein in autoimmune diseases

225

P-GLYCOPROTEIN IN BLOOD BRAIN BARRIER

226

P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity

227

P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus

228

P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors

229

P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway

230

P-GLYCOPROTEIN QUANTITATION IN ACUTE LEUKEMIA

231

P-glycoprotein: Its role in drug resistance

232

P-Glycoprotein-Mediated Efflux and Drug Sequestration in Lysosomes Confer Advantages of K562 Multidrug Resistance Sublines to Survive Prolonged Exposure to Cytotoxic Agents

233

P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice

234

P-glycoproteins are not released into bile

235

PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II

236

PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II

237

PGO: A parallel computing platform for global optimization based on genetic algorithm

238

Pgp deficiency increases amyloid concetrations in the brain

239

PGP4, an ATP Binding Cassette P-Glycoprotein, Catalyzes Auxin Transport in Arabidopsis thaliana Roots

240

PGPR-induced defense responses in the tea plant against blister blight disease

241

pGPro1, a novel binary vector for monocot promoter characterization

242

PGR5 Is Involved in Cyclic Electron Flow around Photosystem I and Is Essential for Photoprotection in Arabidopsis

243

P-graph methodology for cost-effective reduction of carbon emissions involving fuel cell combined cycles

244

p-groups in the Betti-Mathieu group Original Research Article

245

p-GROUPS OF AUTOMORPHISMS OF ABELIAN p-GROUPS

246

p-Groups of Small Breadth

247

p-GROUPS WITH A SMALL NUMBER OF CHARACTER DEGREES AND THEIR NORMAL SUBGROUPS

248

PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan

249

PGS and the Critical Decision on Transfer of Defective Embryos

250

PGSE diffusion NMR studies on mononuclear and dinuclear cationic platinum salts of (S)-MeO-Biphep and (R)-p-tolyl-BINAP

251

PGSS-drying: Mechanisms and modeling

252

p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation Original Research Article

253

pH – Specific synthesis, spectroscopic, and structural characterization of an assembly of species between Co(II) and N,N-bis(phosphonomethyl)glycine. Gaining insight into metal-ion phosphonate interactions in aqueous Co(II)–organophosphonate systems

254

pH adjustment for seasonal control of UF fouling by natural waters Original Research Article

255

pH Affects the Thermal Inactivation Parameters of R-Phycoerythrin from Porphyra yezoensis

256

pH and biogeochemical processes in the Gotland Basin of the Baltic Sea

257

pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method

258

pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method Original Research Article

259

pH and electro-responsive release behavior of MWCNT/PVA/PAAc composite microcapsules

260

pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin

261

pH and glutathion-responsive hydrogel for localized delivery of paclitaxel

262

pH and grain-size variation in leaching tests with bricks made of harbour sediments compared to commercial bricks

263

pH and heat-induced structural changes of bovine apo-α-lactalbumin

264

pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules

265

pH and ionic strength effect on single fibrinogen molecule adsorption on mica studied with AFM

266

pH- and metal-dependent structural diversity from mononuclear to two-dimensional polymers based on a flexible tricarboxylate ligand

267

pH- and mol-ratio dependent formation of zinc(II) coordination polymers with iminodiacetic acid: Synthesis, spectroscopic, crystal structure and thermal studies

268

pH- and mol-ratio dependent tungsten(VI)–citrate speciation from aqueous solutions: syntheses, spectroscopic properties and crystal structures

269

pH and pCO2 microelectrode measurements and the diffusive behavior of carbon dioxide species in coastal marine sediments

270

pH and redox-responsive mixed micelles for enhanced intracellular drug release

271

pH and salt effects on chiral separations using affinity ultrafiltration Original Research Article

272

pH and salt responsive poly(N,N-dimethylaminoethyl methacrylate) cylindrical brushes and their quaternized derivatives

273

pH and salt-induced reversible aggregation of nonionic synthetic glycolipid vesicles

274

pH and solute concentration of suspension media affect the outcome of high hydrostatic pressure treatment of Listeria monocytogenes

275

pH- and sugar-sensitive layer-by-layer films and microcapsules for drug delivery

276

pH and surface tension dependence of mixed sodium deoxycholate–sodium dehydrocholate pre-micellar aggregation in aqueous solution

277

pH and temperature dependence of particle size in Pb1−xFexS nanoparticle films

278

pH and temperature dependent facile precipitation of nano-goethite particles in Fe(NO3)3–NaOH–NH3NH2HSO4–H2O medium

279

pH and temperature responsive porous membranes via an in situ bulk copolymerization approach

280

pH- and temperature-dependent release from cationic vesicles coexisting with copolymer of N-isopropylacrylamide and methacrylic acid

281

pH- and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization

282

pH- and temperature-responsive hydrogels from crosslinked triblock copolymers prepared via consecutive atom transfer radical polymerizations

283

pH- and temperature-responsive poly(aspartic acid)-l-poly(N-isopropylacrylamide) conetwork hydrogel

284

pH- and temperature-sensitive multiblock copolymer hydrogels composed of poly(ethylene glycol) and poly(amino urethane)

285

pH- and temperature-sensitive permeation through polyelectrolyte complex films composed of chitosan and polyalkyleneoxide–maleic acid copolymer

286

pH- and thermo-multi-responsive fluorescent micelles from block copolymers via reversible addition fragmentation chain transfer (RAFT) polymerization

287

pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies

288

pH- and thermosensitive thin lipid layer coated mesoporous magnetic nanoassemblies as a dual drug delivery system towards thermochemotherapy of cancer

289

pH- and time-dependent hemoglobin transitions: A case study for process modelling Original Research Article

290

p–H and T–S diagrams of 3He from 0.2 K to 20 K Original Research Article

291

pH changes in peralkaline late-magmatic fluids

292

pH changes of self-etching primers mixed with powdered dentine

293

pH control for enhanced reductive bioremediation of chlorinated solvent source zones Original Research Article

294

pH control of the structure, composition, and catalytic activity of sulfated zirconia

295

pH control on oxygen isotopic composition of symbiotic corals

296

pH control strategy in astaxanthin fermentation bioprocess by Xanthophyllomyces dendrorhous

297

pH control strategy of batch microbial transglutaminase production with Streptoverticillium mobaraense

298

pH control: handling nonlinearity and deadtime with fuzzy relational model-based control

299

pH controlled condensation of polysiloxane networks at the water–air interface

300

pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media

301

pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media

302

pH controlled emission of ruthenium(II)–tris–bipyridine complexes

303

pH controlled selective transport of proteins through charged ultrafilter membranes under coupled driving forces: An efficient process for protein separation

304

pH controlled size/shape in CTAB micelles with solubilized polar additives: A viscometry, scattering and spectral evaluation

305

pH controlled supramolecular structures of new silver(I) complexes based on 2-sulfoterephthalic acid and 4,4′-bipyridine

306

pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient

307

pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient

308

pH dependant sticking probability of gold colloid on silicon

309

pH dependence and thermodynamics of Hg(II) adsorption onto chitosan-poly(vinyl alcohol) hydrogel adsorbent

310

pH dependence of electrokinetic behavior of dolomite and magnesite in aqueous electrolyte solutions

311

pH Dependence of ferrous sorption onto two smectite clays

312

pH dependence of heme electrochemistry in cytochromes investigated by multiconformation continuum electrostatic calculations

313

pH Dependence of inhibitors targeting the occluding loop of cathepsin B

314

pH dependence of PDMS–PMAA IPN morphology and transport properties

315

pH Dependence of reactive sites of curcumin possessing antioxidant activity and free radical scavenging ability studied using the electrochemical and ESR techniques: Polyaniline used as a source of the free radical

316

pH dependence of steroid hormone—organic matter interactions at environmental concentrations Original Research Article

317

pH dependence of tailing in reversed-phase chromatography of a cationic dye: measurement of the strong adsorption site surface density

318

pH dependence of the absorption and emission behaviour of lumiflavin in aqueous solution

319

pH dependence of the composition and stability of MnIII–bicarbonate complexes and its implication for redox interaction of MnII with photosystem II

320

pH dependence of the dissociation of multimeric hemoglobin probed by high hydrostatic pressure Original Research Article

321

pH dependence of the fluorescence lifetime of enhanced yellow fluorescent protein in solution and cells

322

pH Dependence of the Folding of Intestinal Fatty Acid Binding Protein

323

pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography

324

pH Dependence of the rate of DNA alkylation for (+)-duocarmycin SA and (+)-CCBI-TMI

325

pH Dependence of the Reaction Rate ofp-Bromophenacyl Bromide and of the Binding Constants of Ca2+and an Amide-Type Substrate Analog to Bovine Pancreatic Phospholipase A2

326

pH dependence of the reactions of arsenazo III with the lanthanides

327

pH dependency of ligand binding to cellobiohydrolase 1 (Cel7A): Affinity, selectivity and inhibition for designed propranolol analogues

328

pH dependency of serum ionised calcium Original Research Article

329

pH dependent binding of chlorin-p6 with phosphatidyl choline liposomes

330

pH Dependent binding of chlorin-p6 with phosphatidyl choline liposomes: Comparison between one and two-photon excited fluorescence

331

pH dependent conformational and structural changes of xylanase from an alkalophilic thermophilic Bacillus sp (NCIM 59)

332

pH dependent copper binding properties of a CuA azurin variant with both bridging cysteines replaced with serines

333

pH dependent dynamic behavior of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in femtosecond to nanosecond time scale

334

pH dependent fluorescence switching in salicylideneaniline: ‘off–on–off’ operation controlled by surfactant micelles

335

pH Dependent formations of dinuclear molybdenum(V) and incomplete cubane molybdenum(IV) complexes with nitrilotriacetate

336

pH dependent growth of poly(L-lysine)/poly(L-glutamic) acid multilayer films and their cell adhesion properties

337

pH dependent interaction of biofunctionalized CdS nanoparticles with nucleobases and nucleotides: A fluorimetric study

338

pH dependent phosphate hydrolysis by a lanthanide EF-hand peptide

339

pH Dependent photophysics and role of medium on photoinduced electron transfer between ruthenium polypyridyl complex and anthraquinone

340

pH dependent protein stability: A quantitative approach based on Kramerʹs barrier escape

341

pH dependent reversible aggregation of Chitosan and glycol-Chitosan stabilized silver nanoparticles

342

pH dependent self assembly of (beta)-amyloid(10-35) and (beta)amyloid(10-35)-PEG3000

343

pH Dependent self-assembly of dimetallic lanthanide complexes

344

pH Dependent structural diversity of lead compounds based on new flexible ligand [3-(2-pyridyl)-1-pyrazolyl] acetic acid

345

pH dependent surface enhanced Raman study of Phe + Ag complex and DFT calculations for spectral analysis

346

pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential

347

PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt

348

PH effect in the photocatalytic transformation of a phenyi-urea herbicide

349

pH effect on cysteine and cystine behaviour at hanging mercury drop electrode

350

pH effect on OH radical production in photo/ferrioxalate system

351

pH Effect on the binding of chlorin derivatives with Cremophor EL, a potential drug delivery vehicle

352

pH effect on the electrochemical redox reaction of disulfide with polyaniline film electrode in organic solution

353

pH Effect on the Size of Graphene Quantum dot Synthesized by Using Pulse Laser Irradiation

354

pH Effect on the spectroscopic behavior and photoinduced generation of semiquinone anion radical of hypocrellin B

355

pH effects on collagen fibrillogenesis in vitro: Electrostatic interactions and phosphate binding

356

pH effects on drug interactions with lipid bilayers by liposome electrokinetic chromatography

357

pH effects on optical and DNA binding properties of a thiophene-containing ruthenium(II) complex

358

pH effects on the adherence and fouling propensity of extracellular polymeric substances in a membrane bioreactor

359

pH effects on the binding of oxygen to non-vertebrate monomeric hemoglobins. A linked function model.

360

pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer

361

pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins. Part III. The electrostatic non-specific hyaluronan–hyaluronidase complex

362

pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part II. The electrostatic hyaluronan – Protein complexes

363

pH effects on the second-order nonlinear optical properties of surface modified CdS nanoparticles

364

pH evolution in sea ice grown at an outdoor experimental facility

365

P–H functionalised phosphinoalkoxides as ligands: synthesis and catalytic properties of [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp)-C6H10)] (Tipp=2,4,6-Pri3C6H2), [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp){Mo(CO)5}–C6H10)] and [Cp2Zr(BH4)(cyclo-1-O-2-PH(Mes)(BH3)–C6H10)] (Mes=2

366

pH gradient high-performance liquid chromatography: theory and applications

367

pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides

368

pH has a role in cystic fibrosis infections

369

pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque

370

pH HOMEOSTASIS OF THE CIRCADIAN SPORULATION RHYTHM IN CLOCK MUTANTS OF NEUROSPORA CRASSA

371

pH Independent Complexation of 2-Aminobenzimidazole with β-cyclodextrin

372

pH indications in aqueous organic photodecompositions with carbonyl and hydroxyl groups

373

pH Induced Aggregation and Weak Gel Formation of Whey Protein Polymers

374

pH influence on root growth and nutrient uptake of Pinus pinaster seedlings

375

pH influence on sorption characteristics of heavy metal in the vadose zone

376

pH Influence on the stability of foams with protein–polysaccharide complexes at their interfaces

377

pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils

378

pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils

379

pH measurement and control in solvent extraction using column contractors

380

pH MEASUREMENT USING MICRO GAP STRUCTURE

381

pH Metric, Spectroscopic and Thermodynamic Study of Complexation Behavior of 2-aminobenzothiazole with Ni (II) in Presence of Amino Acids

382

pH microelectrode–micropipette system for the measurement of enzyme reactions in a picoliter volume of a living plant cell Original Research Article

383

pH modelling by neural networks. Application of control and validation data series in the Middle Loire river

384

pH modelling by neural networks. Application of control and validation data series in the Middle Loire river

385

pH Modulates the Quinone Position in the Photosynthetic Reaction Center from Rhodobacter sphaeroides in the Neutral and Charge Separated States

386

pH modulation of transport properties of alamethicin oligomers inserted in zwitterionic-based artificial lipid membranes Original Research Article

387

pH neutralization and influence on mechanical strength in self-adhesive resin luting agents

388

pH of activated carbon surface as an indication of its suitability for H2S removal from moist air streams Original Research Article

389

390

pH of soul: How does acid-base balance affect our cognition?

391

pH of the Martian surface

392

pH optical sensors based on sol–gels: Chemical doping versus covalent immobilization Original Research Article

393

pH Oscillations and complex reaction dynamics in the non-buffered chlorite–thiourea reaction

394

pH polymeric membrane microelectrodes based on neutral carriers and their application in aquatic environments Original Research Article

395

pH pre-corrected liquid hot water pretreatment on corn stover with high hemicellulose recovery and low inhibitors formation

396

pH programming in capillary electrophoresis by means of temperature programming

397

pH regulates key players of nitrification in paddy soils

398

pH regulates key players of nitrification in paddy soils

399

pH regulation as a method of intensification of soil electroremediation

400

pH regulation during ischaemia-reperfusion of isolated rat hearts, and metabolic effects of 2,3-butanedione monoxime

401

pH Regulation in Anoxic Plants

402

pH regulation of alkaline wastewater with carbon dioxide: A case study of treatment of brewery wastewater in UASB reactor coupled with absorber

403

pH regulation of carbon and nitrogen dynamics in two agricultural soils

404

pH regulation of carbon and nitrogen dynamics in two agricultural soils

405

pH responsive “off–on–off” luminescent switch of a novel ruthenium(II) complex [Ru(bpy)2(pipipH2)]2+

406

pH responsive cross-linked polymeric matrices based on natural polymers: effect of process variables on swelling characterization and drug delivery properties

407

pH responsive itaconic acid grafted alginate microspheres for the controlled release of nifedipine

408

pH responsive luminescent switches of ruthenium(II) complexes containing two imidazole groups: Synthesis, spectroscopy, electrochemistry and theoretical calculations

409

pH Responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier

410

pH responsiveness of two-layer nano-composite membrane with ultrathin cylindrical nanopores PS-b-P4VP film

411

pH sensing in living cells using fluorescent microspheres

412

pH sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery

413

pH Sensitive Hydrogel Based Acrylic Acid for Controlled Drug Release

414

pH Sensitive Hydrogel Based on Poly(Acrylic Acid) and Cellulose Nanocrystals

415

pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery

416

pH sensitive photoconductor based on poly(para-phenylene-vinylene)

417

pH sensitive photoconductor based on poly(para-phenylene-vinylene)

418

pH Sensitive polypropylene porous membrane prepared by grafting acrylic acid in supercritical carbon dioxide

419

pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery

420

pH Sensitive supramolecular assembling system between a new linear water soluble β-cyclodextrin terpolymer and an amphiphilic poly(ethylene oxide)

421

pH sensitivity of polyaniline and its substituted derivatives

422

pH sensor based on a detection sol–gel layer onto optical fiber

423

pH sensor based on deposited film of lead oxide on aluminum substrate electrode

424

pH sensor based on the crown heteropolyanion K28Li5H7P8W48O184·92H2O immobilized using a layer by layer assembly process

425

pH sensors with lithium lanthanum titanate sensitive material: applications in food industry

426

pH sequential ozonation of domestic and wine-distillery wastewaters

427

pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)

428

pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)

429

pH stress can cause cell elongation in Bacillus and Clostridium species: a research note

430

pH Switched sensitisation of europium(III) by a dansyl group

431

pH switching on-off semi-IPN hydrogel based on cross-linked poly(acrylamide-co-acrylic acid) and linear polyallyamine

432

pH transients in hydroxyapatite chromatography columns—Effects of operating conditions and media properties

433

pH Transients in hydroxyapatite chromatography columns—Experimental evidence and phenomenological modeling

434

pH transitions in cation exchange chromatographic columns containing weak acid groups

435

pH Transitions in Ion-Exchange Systems: Role in the Development of a Cation-Exchange Process for a Recombinant Protein

436

pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes

437

pH tunable morphology of the gold nanoparticles produced by citrate reduction

438

pH value and ionic strength effects on the adsorption kinetics of protein/phospholipid at the chloroform/water interface

439

pH Value controlled structures: from macrocyclic complex monomer to 2D macrocyclic sheet

440

pH value dependence of the photothermal and optical absorption spectra for polyaniline films

441

pH variability and CO2 induced acidification in the North Sea

442

pH, alkalinity and total CO2 in coastal seawater by potentiometric titration with a difference derivative readout Original Research Article

443

pH, Dissolved Oxygen, and Adsorption Effects on Metal Removal in Anaerobic Bioreactors

444

pH, Photo, and Aeration Period Effects on Arthrospira maxima Growth: Taguchi Technique

445

pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures

446

Ph.D. in Business Management at Istanbul University: A New Programme in English Ready to Commence in Fall 2016

447

Ph.D. in Nursing from Theory to Reality

448

Ph.D. Students of Irving Segal

449

pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate

450

pH/Temperature control of interpolymer complexation between poly(acrylic acid) and weak polybases in aqueous solutions

451

pH/temperature sensitive poly(ethylene glycol)-based biodegradable polyester block copolymer hydrogels

452

pH/temperature-responsive behaviors of semi-IPN and comb-type graft hydrogels composed of alginate and poly(N-isopropylacrylamide)

453

pH/temperature-sensitive 4-arm poly(ethylene glycol)-poly(amino urethane) copolymer hydrogels

454

Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results

455

Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results

456

Ph3BiCO3: a mild reagent for in situ oxidation of urazoles to triazolinediones

457

Ph3P/Br2/n-Bu4NNO2 as an efficient system for the preparation of N-nitrosamines and azides

458

PHA based denitrification: Municipal wastewater vs. acetate

459

PHA immune response assay in captive zebra finches is modulated by activity prior to testing

460

PHA production by mixed cultures: A way to valorize wastes from pulp industry

461

PHA production from wastewater by mixed microbial culture under short-term microbial enrichment

462

PHA stimulation may be useful for FDXR gene expression-based biodosimetry

463

PHA/IL2: An Efficient Mitogen Cocktail for Cytogenetic Studies of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

464

PHA: A fast potential-based hierarchical agglomerative clustering method

465

PHAC SYNTHASES AND PHA DEPOLYMERASES: THE ENZYMES THAT PRODUCE AND DEGRADE PLASTIC

466

PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations

467

PHACES (Photographs of Academic Clinicians and Their Educational Status): A Tool to Improve Delivery of Family-Centered Care

468

PHACES syndrome with cataract and Horner’s syndrome: a case report

469

Phaco chop: Matering technique, optimizing technology, and avoiding complication

470

Phacodynamic: An Apiration Flow v Vacuum Comparion

471

Phacodynamic: Matering the Tool and Technique of Phacoemulification urgery; Fourth Edition

472

Phacoemulification and len implantation after cleral buckling urgery

473

Phacoemulification Aociated Corneal Damage Evaluated by Corneal Volume

474

Phacoemulification cataract extraction and poterior chamber len implantation in patient with uveiti

475

Phacoemulification of Cataract in Patient Receiving Coumadin Therapy: Ocular and Hematologic Rik Aement Original Reearch Article

476

Phacoemulification v mall-Inciion Manual Cataract urgery: An Expert Trial

477

Phacoemulsification of bilateral cataracts in two pet rabbits

478

Phacomorphic Glaucoma as the First Manifestation of the Choroidal Malignant Melanoma

479

Phacotrabeculectomy and Implantation of Intraocular Lenses with Releasable Sutures and Antimetabolite Agents: Efficacy and Safety

480

Phacotrabeculectomy With Mitomycin C in Patient With Uveiti

481

Phae I/II randomized trial of intrahepatic arterial infuion chemotherapy with ciplatin and chemoembolization with ciplatin and polyvinyl ponge in patient with ocular melanoma metatatic to the liver

482

Phaehyphomycosis caused by Veronea bothryosa

483

Phaeoacremonium tuscanicum, a new fungal pathogen associated with oak decline in Zagros forests, Iran

484

Phaeochromocytoma

485

Phaeochromocytoma—views on current management

486

Phaeocystis blooms in the global ocean and their controlling mechanisms: a review

487

Phaeohyphomycosis caused by Diaporthe phaseolorum in an immunocompetent patient in Thailand: a case report

488

Phaeomoniella chlamydospora: causal agent of vine decline (Vitis vinifera) in the vineyards of Slovakia

489

Phaeophytins from Gossypium mustelinum Miers ex Watt (Malvaceae)

490

Phage adsorption to Lactobacillus plantarum: Influence of physiological and environmental factors

491

Phage coated magnetoelastic micro-biosensors for real-time detection of Bacillus anthracis spores

492

Phage Display and Crystallographic Analysis Reveals Potential Substrate/Binding Site Interactions in the Protein Secretion Chaperone CsaA from Agrobacterium tumefaciens

493

Phage display as a tool for the directed evolution of enzymes

494

Phage display combinatorial libraries of short peptides: ligand selection for protein purification

495

Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope

496

Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope

497

Phage display of functional, full-length human and viral membrane proteins

498

Phage Display Reveals Multiple Contact Sites between FhuA, an Outer Membrane Receptor of Escherichia coli, and TonB

499

Phage Display Screening Reveals an Association Between Germline-specific Transcription Factor Oct-4 and Multiple Cellular Proteins

500

Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites

501

Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites

502

Phage display techniques to obtain antibodies against turbot (Scophthalmus maximus) blood cells

503

Phage display technology for stem cell delivery and systemic therapy

504

Phage display technology: clinical applications and recent innovations

505

Phage FR38 Treatment on Sprague Dawley Rat Inferred from Blood Parameters and Organ Systems

506

Phage Genomics: Small Is Beautiful

507

Phage inactivation of foodborne pathogens on cooked and raw meat

508

Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses

509

Phage Integrases: Biology and Applications Review Article

510

Phage Langmuir monolayers and Langmuir–Blodgett films

511

Phage Like It HOT: Solution Structure of the Bacteriophage P1-Encoded HOT Protein, a Homolog of the θ Subunit of E. coli DNA Polymerase III

512

Phage ø29 DNA polymerase residues involved in the proper stabilisation of the primer-terminus at the 3′-5′ exonuclease active site

513

Phage P22 Procapsids Equilibrate with Free Coat Protein Subunits

514

Phage Peptide Libraries As a Source of Targeted Ligands

515

Phage selection for site-specific incorporation of unnatural amino acids into proteins in vivo Original Research Article

516

Phage Therapy in COVID-19 Treatment

517

Phage therapy: A modern tool to control bacterial infections

518

Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice

519

Phage therapy—advantages over antibiotics?

520

Phage Types of multidrug resistant Salmonella species in a rural area of Maharashtra, India

521

Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru)

522

Phage typing combined with pulsed-field gel electrophoresis and random amplified polymorphic DNA increases discrimination in the epidemiological analysis of Salmonella enteritidis strains

523

Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus

524

Phage versus Phagemid Libraries for Generation of Human Monoclonal Antibodies

525

Phage λ takes the first exit

526

Phage-based nanomaterials for biomedical applications

527

Phage-borne peptidomimetics as immunochemical reagent in dot-immunoassay for mycotoxin zearalenone

528

Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions

529

Phage-displayed peptide library screening for preferred human substrate peptide sequences for transglutaminase 7

530

Phage-displayed peptides that mimic zearalenone and its application in immunoassay

531

Phage-displayed protein chip based on SPR sensing

532

Phagemid Vectors for Phage Display: Properties, Characteristics and Construction Review Article

533

Phage-peptide Display Identifies the Interferon-responsive, Death-activated Protein Kinase Family as a Novel Modifier of MDM2 and p21WAF1

534

Phage-related DNA polymorphism in dairy and probiotic Lactobacillus

535

Phage-resistance linked to cell heterogeneity in the commercial strain Lactobacillus delbrueckii subsp. lactis Ab1

536

Phage-resistant mutants of Lactobacillus delbrueckii may have functional properties that differ from those of parent strains

537

Phagocyte functions in stressed rats: comparison of modulation by glutamine, arginine and ornithine 2-oxoglutarate

538

Phagocyte implications in advanced atherosclerosis

539

Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers

540

Phagocyte-Generated Superoxide Reduces Fe3+ to Displace It from the Surface of Asbestos

541

Phagocyte-induced lipid peroxidation of different intravenous fat emulsions and counteractive effect of vitamin E

542

Phagocyte–myocyte interactions and consequences during hypoxic wound healing

543

Phagocytes and oxidative stress

544

Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules

545

Phagocytic Activity and IL-1 Alpha Levels for Asthma Patients

546

Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent

547

Phagocytic Activity of Patients with a Diabetic Foot in Wasit Province, Iraq

548

Phagocytic activity of scallop (Pecten maximus) haemocytes maintained in vitro

549

Phagocytic activity of turbot (Scophthalmus maximus) leucocytes: opsonic effect of antibody and complement

550

Phagocytic activity of two lines of chickens divergently selected for antibody production

551

Phagocytic activity of two lines of chickens divergently selected for antibody production

552

Phagocytic and chemotactic responses of manila and carpet shell clam haemocytes against Vibrio tapetis, the causative agent of brown ring disease

553

Phagocytic and Metabolic Activities of Macrophages from Mummichog Naturally Exposed to Pulp Mill Effluents in the Miramichi River

554

Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia

555

Phagocytic cells of the thymic reticulum interact with thymocytes via extracellular matrix ligands and receptors

556

Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells

557

Phagocytic killing of microorganisms by radical processes:consequences of the reaction of hydroxyl radicals with chloride yielding chlorine atoms

558

Phagocytic response of macrophages from the pronephros of American plaice (Hipoglossoides platessoides) exposed to contaminated sediments from Baie des Anglais, Quebec

559

Phagocytic Response of Terrestrial and Aquatic Invertebrates Following in Vitro Exposure to Trace Elements

560

Phagocytosis and development: back to the future

561

Phagocytosis and innate immunity

562

Phagocytosis and respiratory burst activity of haemocytes from the ivory snail, Babylonia areolata

563

Phagocytosis by B-cells and neutrophils in Atlantic salmon (Salmo salar L.) and Atlantic cod (Gadus morhua L.)

564

Phagocytosis in pup and adult harbour, grey and harp seals

565

Phagocytosis in pup and adult harbour, grey and harp seals

566

Phagocytosis inhibition of clam and mussel haemocytes by Perkinsus atlanticus secretion products.

567

Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages

568

Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages

569

Phagocytosis of candida albicans by lymphatic tumour cells in vitro

570

Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro

571

Phagocytosis of chemically modified carbon materials

572

Phagocytosis of Loma salmonae (Microsporidia) spores in Atlantic salmon (Salmo salar), a resistant host, and chinook salmon (Oncorhynchus tshawytscha), a susceptible host

573

Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production

574

Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition

575

Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication

576

Phagocytotic removal of apoptotic endocrine cells by folliculostellate cells and its functional implications in clusterin accumulation in pituitary colloids in helmeted guinea fowl (Numida meleagris)

577

Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages

578

Phagotrophic algae in a wastewater stabilization pond

579

PHAHs in 14 principal river sediments from Hai River basin, China Original Research Article

580

Phakic Intraocular Lenses and their Special Indications

581

Phakic IOL: A photo finih?

582

Phakic poterior chamber intraocular len for the correction of aniometropia and treatment of amblyopia

583

Phakomatosis pigmentovascularis type IIa

584

Phalangeal osteochondroma: a cause of childhood trigger finger

585

Phalangeal osteosonogrammetry age-related changes and assessment of a Lebanese reference population

586

Phalangeal Tuberculosis After Mallet Finger Treatment: A Case Report

587

Phalangeal ultrasonography in forearm fracture discrimination

588

Phalanx-like osseous structure posterior to the cervical vertebrae: a hitherto unreported location for a rare anomaly

589

Phalaropes feeding at a coastal front in Santa Monica Bay, California

590

PHALEN TEST POSITIVATION TIME an‎d ITS CORRELATION WITH ELECTRONEUROMYOGRAPHY

591

Phallometric testing with sexual offenders: Limits to its value

592

Phalloplasty for an amputated phallus in intersex patients

593

Phalloplasty in female-to-male transsexuals using free radial osteocutaneous flap: a series of 22 cases, ,

594

Phanerochaete chrysosporium pretreatment of biomass to enhance solvent production in subsequent bacterial solid-substrate cultivation

595

Phanerochaete flavido-alba ligninolytic activities and decolorization of partially bio-depurated paper mill wastes

596

Phanerozoic atmospheric CO2 change: evaluating geochemical and paleobiological approaches

597

Phanerozoic biodiversity: rocks or real?

598

Phanerozoic burial and unroofing history of the western Slave craton and Wopmay orogen from apatite (U–Th)/He thermochronometry

599

Phanerozoic changes in the high-rank suprageneric diversity structure of brachiopods: Linear and non-linear effects

600

Phanerozoic continental growth and gold metallogeny of Asia

601

Phanerozoic Continental Growth of East and Southeast Asia: Timings of Amalgamation and Accretion

602

Phanerozoic Geodynamic Evolution of the Circum-Italian Realm

603

Phanerozoic high-pressure eclogite and intermediate-pressure granulite facies metamorphism in the Gyeonggi Massif, South Korea: Implications for the eastward extension of the Dabie–Sulu continental collision zone

604

Phanerozoic hot spot traces and paleogeographic reconstructions of the Siberian continent based on interaction with the African large low shear velocity province

605

Phanerozoic Large Igneous Provinces (LIPs), HEATT (Haline Euxinic Acidic Thermal Transgression) episodes, and mass extinctions

606

Phanerozoic marine biodiversity follows a hyperbolic trend

607

Phanerozoic organic-carbon-rich marine sediments: Overview and future research challenges

608

Phanerozoic paleogeography, paleoenvironment and lithofacies maps of the circum-Atlantic margins

609

Phanerozoic polar wander, palaeogeography and dynamics

610

Phanerozoic reactivation along a fundamental Proterozoic crustal fault, the Darling River Lineament, Australia: constraints from apatite fission track thermochronology

611

Phanerozoic reactivation of the Archean North China Craton through episodic magmatism: Evidence from zircon U–Pb geochronology and Hf isotopes from the Liaodong Peninsula

612

Phanerozoic Reconstitution of Indian Shield as Aftermath of Gondwana Break-up

613

Phanerozoic tectonics of the South China Block: Key observations and controversies

614

Phanerozoic tectonothermal events of the Xuefengshan Belt, central South China: Implications from UPb age and LuHf determinations of granites

615

Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology

616

Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology

617

Phanquinone: a useful fluorescent pre-chromatographic derivatization reagent for liquid chromatographic analyses of amino acid dosage forms Original Research Article

618

PHANTASTICA Regulates Development of the Adaxial Mesophyll in Nicotiana Leaves

619

Phantom accretion by black holes and the generalized second law of thermodynamics

620

Phantom and in vivo study of the look–locher T1 mapping method

621

Phantom Archean crust in Mangaia hotspot lavas and the meaning of heterogeneous mantle

622

Phantom bursting is highly sensitive to noise and unlikely to account for slow bursting in -cells: Considerations in favor of metabolically driven oscillations

623

Phantom dosimeters examined by NMR analysis: a promising technique for 3-D determination of absorbed dose

624

Phantom elasticity reconstruction with Digital Image Elasto-Tomography

625

Phantom endometriosis of the sciatic nerve

626

Phantom evolution in power-law potentials Original Research Article

627

Phantom faces for face analysis

628

Phantom feelings in the thalamus explained

629

Phantom Friedmann cosmologies and higher-order characteristics of expansion

630

Phantom limb after stroke: An underreported phenomenon

631

Phantom limb pain

632

Phantom limb pain

633

Phantom limb pain in pediatric burn survivors

634

Phantom Limb Sensation (PLS) and Phantom Limb Pain (PLP) among Young Landmine Amputees

635

PHANTOM LIMB SYNDROME: A REVIEW

636

Phantom limbs – Or phantoms of phantom limbs?

637

Phantom maps and homology theories

638

Phantom Maps and Purity in Modular Representation Theory, III

639

Phantom maps and the Gray index

640

Phantom Maps in the Stable Module Category

641

Phantom materials for single point imaging pulse sequences

642

Phantom nurses at real bedsides

643

644

Phantom reflexes: Muscle contractions at a frequency not physically present in the input stimuli

645

Phantom study of radiotracer concentration quantification in breast scintigraphy

646

Phantom thermodynamics Original Research Article

647

Phantom tumor of the lung in heart failure patient

648

Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device

649

PHANTOM: A Monte Carlo event generator for six parton final states at high energy colliders Original Research Article

650

Phantom: a simple and effective flow control scheme

651

Phantom-based performance evaluation: Application to brain segmentation from magnetic resonance images

652

Phantom-like behaviour in dilatonic brane-world scenario with induced gravity Original Research Article

653

Phantom-limb lengthening after heart transplant

654

Phantom-limb pain: characteristics, causes, and treatment

655

Phantom-node method for shell models with arbitrary cracks

656

Phantoms and spectres: capital and labour at the millennium

657

Phantoms of regularity in the sea of quantum chaos

658

PhAP protease from Pseudoalteromonas haloplanktis TAC125: Gene cloning, recombinant production in E. coli and enzyme characterization

659

Phar Lap and duodenitis-proximal jejunitis

660

Pharaoh and the Divine Wont of Respiting: A Critical Analysis of Quranic Themes

661

PHARAOH EAGLE-OWL BUBO ASCALAPHUS (SAVIGNY, 1809) (STRIGIFORMES, STRIGIDAE), THE “SHROUDED IN MYSTERY” OWL OF IRAQ an‎d IRAN

662

Pharmaceutical Advances and Proteomics Researches

663

Pharmaceutical advertising versus research spending: are profits more important than patients?

664

Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues

665

Pharmaceutical Analysis, D.C. Lee, M. Webb (Eds.). Blackwell Publishing Ltd, Oxford, UK (2003)

666

Pharmaceutical and Bio-analytical Applications of Ion Mobility Spectrometry for Determination of Clopidogrel (Plavix)

667

Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy

668

Pharmaceutical and clinical aspects of p-phenylene-diamine patch test material

669

PHARMACEUTICAL AND CLINICAL EVALUATION OF INTRAVENOUS ADMIXTURE OF DOBUTAMINE AND DOPAMINE USED IN TREATMENT HYPOTENSION IN NEONATAL INTENSIVE CARE UNITS

670

Pharmaceutical and industrial protein engineering: Where we are?

671

Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract

672

Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives

673

Pharmaceutical and personal care products (PPCPs) in urban receiving waters l

674

Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field Original Research Article

675

Pharmaceutical and Related Drugs

676

Pharmaceutical applications of a flurbiprofen sensor

677

Pharmaceutical applications of calorimetric measurements in the new millennium

678

Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems

679

Pharmaceutical applications of dynamic mechanical thermal analysis

680

Pharmaceutical applications of embryonic stem cells

681

Pharmaceutical applications of isoelectric focusing on microchip with imaged UV detection

682

Pharmaceutical applications of magnetic resonance imaging (MRI)

683

Pharmaceutical applications of Mid-IR and Raman spectroscopy

684

Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies

685

Pharmaceutical applications of various natural gums, mucilages and their modified forms

686

Pharmaceutical Approaches and Advancements in Male Contraception

687

Pharmaceutical aspects of parenteral nutrition: from now to the future

688

Pharmaceutical Care Approach to Hearing Loss

689

Pharmaceutical Care Education and Practice in Jordan in the New Millennium

690

Pharmaceutical Care Program for Patients With Uncontrolled Hypertension: Report of a Double-Blind Clinical Trial With Ambulatory Blood Pressure Monitoring

691

Pharmaceutical challenges in veterinary product development

692

Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model

693

Pharmaceutical Characterization of Aqueous Stem Bark Extract of Bridelia ferruginea Benth (Euphorbiaceae)

694

Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment

695

Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation

696

Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications

697

Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development

698

Pharmaceutical companies and the third world

699

Pharmaceutical companies pay criminal fine for fxobal price fixing

700

Pharmaceutical companies pledge vaccines for developing countries

701

Pharmaceutical companies target plant products for drugs of the future

702

Pharmaceutical company trials and the integrity of medical research

703

Pharmaceutical Compounds as Photostabilizers

704

Pharmaceutical cost management and access to psychotropic drugs: The U.S. context

705

Pharmaceutical economy and the economic assessment of drugs in France

706

Pharmaceutical Electrochemistry: the Electrochemical Behaviour of Paracetamol at ZnO Nanoparticales/1, 2-Napthaquinone-4-Sulphonic Acid Glassy Carbon Modified Electrode

707

Pharmaceutical Equivalence of Some Commercial Samples of Artesunate and Amodiaquine Tablets Sold in Southwestern Nigeria

708

Pharmaceutical Evaluation of Metformin HCl Products Available in the Jordanian Market

709

Pharmaceutical Evaluation of Ziziphus Jujuba Mucoadhesive Buccal Film

710

Pharmaceutical Excipient Development: The Need for Preclinical Guidance

711

Pharmaceutical Formulation of Garlic and Turmeric Dried Crude Extract and Their Synergistic Antifungal Activity and Safety

712

Pharmaceutical haute couture: educating patients about health-care choices

713

Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives

714

Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications

715

Pharmaceutical industry profits and cost to senior citizensʹ health

716

Pharmaceutical Industry Roundtable Abstracts

717

Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009

718

Pharmaceutical laws and regulations in Iran: An overview

719

Pharmaceutical microcalorimetry: recent advances in the study of solid state materials

720

Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications

721

Pharmaceutical Nanoparticles and the Mucin Biopolymer Barrier

722

Pharmaceutical nanotechnology for oral delivery of anticancer drugs

723

Pharmaceutical Nickel(II) Chelation Properties of 3-Hydroxyflaven, Deferiprone and Maltol Metal Chelators: A Density Functional Study

724

Pharmaceutical patent analyst – FutureScience publishing

725

Pharmaceutical patents on plant derived materials in Brazil: Policy, law and statistics

726

Pharmaceutical policies used by private health insurance companies in Saudi Arabia

727

Pharmaceutical powder technology — from art to science: the challenge of the FDAʹs Process Analytical Technology initiative

728

Pharmaceutical powders analysis using FT-Raman spectrometry: Simultaneous determination of sulfathiazole and sulfanilamide

729

Pharmaceutical powders compaction: Experimental and numerical analysis of the density distribution

730

pharmaceutical prescription (Rx): Calcium, phosphate, and secundum artem

731

Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography–mass spectrometry

732

Pharmaceutical Properties of Hibiscus sabdariffa, Toward an Ideal Treatment for Hypertension

733

Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing

734

Pharmaceutical representatives

735

Pharmaceutical representatives’ beliefs and practices about their professional practice: a study in Sudan

736

Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck

737

Pharmaceutical research: paradox, challenge or dilemma?

738

Pharmaceutical risk management in Turkey: The first national overview

739

Pharmaceutical Statistics Using SAS®: A Practical Guide by Alex Dmitrienko, Christy Chuang-Stein, Ralph DʹAgostino

740

Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors

741

Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines

742

Pharmaceutical supply chain risks: a systematic review

743

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation

744

Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography–ion trap tandem mass spectrometry

745

Pharmaceutical Wastewater Chemical Oxygen Demand Reduction: Electro-Fenton, UV-enhanced Electro-Fenton and Activated Sludge

746

Pharmaceutical wastewater treatment by membrane bioreactor process – a case study in southern Taiwan Original Research Article

747

Pharmaceutical workers

748

PHARMACEUTICAL, FOOD AND NON-FOOD APPLICATIONS OF MODIFIED STARCHES: A CRITICAL REVIEW

749

Pharmaceutical-enantiomers resolution using immobilized polysaccharide-based chiral stationary phases in supercritical fluid chromatography

750

Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA

751

Pharmaceuticals and personal care products (PPCPs) in foods. Potential risks to human health?

752

Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada

753

Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina Original Research Article

754

Pharmaceuticals and the Strategic National Stockpile Program

755

Pharmaceuticals in Australia: developments in regulation and governance

756

Pharmaceuticals in groundwaters: Analytical methods and results of a monitoring program in Baden-Württemberg, Germany

757

PHARMACEUTICALS IN IRAN: AN OVERVIEW

758

Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment

759

Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies

760

Pharmaceuticals in the river Elbe and its tributaries

761

Pharmaceuticals Safety Practices-A Comparative Pilot Study

762

Pharmaceuticals Solubility is Still Nowadays Widely Studied Everywhere

763

Pharmaceuticals, alkylphenols and pesticides in Mediterranean coastal waters: Results from a pilot survey using passive samplers

764

Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada — Occurrence and treatment efficiency Original Research Article

765

Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system Original Research Article

766

Pharmaceuticals: a threat to drinking water? Original Research Article

767

Pharmaceuticals—our true clinical partners?

768

Pharmaciesʹ over-the-counter drug monopoly in Denmark ended

769

Pharmacies, self-medication and pharmaceutical marketing in Bombay, India

770

Pharmacist and nurse: a team approach towards primary health care or a convenient “therapeutic alliance”? Original Research Article

771

Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach

772

PHARMACIST ROLE IN GLOBAL HEALTH: A REVIEW OF LITERATURE

773

Pharmacist, the pharmaceutical industry and pharmacy education in Saudi Arabia: A questionnaire-based study

774

Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process

775

Pharmacist-Led Medication Review: Supports for New Role of Pharmacists

776

PHARMACIST-MANAGED THERAPEUTIC DRUG MONITORING SERVICE FOR ANTIEPILEPTIC DRUGS AND IMPROVED SEIZURE CONTROL

777

Pharmacist-Physician Organic Cooperation Is an Effective Strategy to Reduce the Medication-related Problems, An Experience in CKD Patients

778

Pharmacists agree: stop the pharmacy madness

779

Pharmacists as Entrepreneurs or Employees: The Role of Locus of Control

780

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study

781

PHARMACISTS UNDERSTANDING AND ATTITUDES TOWARDS PHARMACEUTICAL CARE IN SAUDI ARABIA

782

Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study

783

Pharmacists’ Attitudes and Perceived Barriers about Community Pharmacy-Based Cardiovascular Risk Screening Services

784

PHARMACISTS’ NEGLIGENCE AND PRINCIPLES OF LIABILITY

785

Pharmacists’ Perception of the Sale of Non-Clinically Proven Health Supplements in Penang, Malaysia

786

Pharmaco1logic Evaluation of the Calcitonin Analogue SB 205614 in Models of Osteoclastic Bone Resorption In Vitro and In Vhro: Comparison With Salmon Calcitonin and Elcatonin

787

Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days

788

Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: An isobolographic analysis

789

Pharmacodynamic Effect of N-Acetylcysteine as Adjunctive Therapy in Mild Systemic Lupus Erythematosus Patients

790

Pharmacodynamic effects of milrinone with and without a bolus loading infusion

791

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Patients on Maintenance Prasugrel Therapy: Results of a Prospective Randomized Study

792

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)

793

PHARMACODYNAMIC INTERACTION OF GARLIC WITH PROPRANOLOL IN ISCHEMIA-REPERFUSION INDUCED MYOCARDIAL DAMAGE

794

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects Original Research Article

795

Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro

796

Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects

797

Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide

798

Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae

799

Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats

800

Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models

801

Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection

802

Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration

803

Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration

804

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of ilgrastim

805

Pharmacodynamics in the elderly

806

Pharmacodynamics of alpha2-adrenoceptor agonists

807

Pharmacodynamics of antimicrobial therapy in surgery

808

Pharmacodynamics of immunosuppressive drugs

809

Pharmacodynamics of Intermittent- and Continuous-Infusion Gefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model

810

Pharmacodynamics of mivacurium in severely burned patients

811

Pharmacodynamics of warfarin in cats

812

Pharmacodynamics Studies on Ricobendazole In Male Rats

813

Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia

814

Pharmacodynamics: Relation to Antimicrobial Resistance

815

Pharmacodynamics: Relation to antimicrobial resistance

816

Pharmacoeconomic Aspects of Treating Hemorrhoidal Disease-Cost of Illness Study Based on Data from Balkan Country with Recent History of Social and Economic Transition

817

Pharmacoeconomic assessment of midazolam in two emergency departments

818

Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina

819

Pharmacoeconomic Evaluation of Anti-Diabetic Therapy in A Nigerian Tertiary Health Institution

820

Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes

821

Pharmacoeconomic Impact Evaluation of Statin Adherence in High-risk Unselected Post Myocardial Infarction Population: an Administrative Database-guided Analysis

822

Pharmaco-economic issues for diabetes therapy

823

Pharmacoeconomic issues in antihypertensive therapy

824

Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital

825

Pharmacoeconomics Analysis in a Pediatric Population

826

Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system

827

Pharmacoeconomics and health outcomes: state of the art

828

Pharmacoeconomics and Utilization of Intravenous Iron Sucrose in a Tertiary Care Hospital

829

Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital

830

Pharmacoeconomics for surgeons

831

Pharmacoeconomics in Iran: It Is Time to Take It into Practice

832

Pharmacoeconomics of Angiotensin Converting Enzyme Inhibitors in Heart Failure

833

PHARMACO-ECONOMICS OF MICRODOSING CLINICAL TRIALS IN DRUG DEVELOPMENT PROCESS

834

Pharmacoeconomics of pneumonia

835

Pharmacoeconomics: what is it and where is it going?

836

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?

837

Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam

838

Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt

839

Pharmacoepidemiology of Drugs Used in Indoor Patients of Orthopaedic Department at a Tertiary Care Hospital

840

Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy

841

Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients

842

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure Original Research Article

843

Pharmacogenetic prediction of clozapine response Original Research Article

844

Pharmacogenetic Studies of Depression

845

Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation

846

Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients

847

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs

848

Pharmacogenetics and adverse drug reactions

849

Pharmacogenetics and antipsychotic drugs

850

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients

851

Pharmacogenetics and future drug development and delivery

852

Pharmacogenetics and Personalized Medicine in Pancreatic Cancer

853

Pharmacogenetics draws an ACE

854

Pharmacogenetics in Cardiovascular Antithrombotic Therapy

855

Pharmacogenetics of anti-estrogen treatment of breast cancer

856

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

857

Pharmacogenetics of clozapine response

858

Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances

859

Pharmacogenetics of disease-modifying anti-rheumatic drugs

860

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

861

Pharmacogenetics of inflammatory bowel disease

862

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

863

Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy

864

Pharmacogenetics, the Promise of Translating Personalized Medicine into Clinical Pediatrics

865

Pharmacogenetics: Fitting the Drug to the Patient

866

Pharmacogenetics: Is the right drug for the right patient sufficient?

867

Pharmacogenetics: Yeast Lead the Way

868

Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients

869

Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients

870

Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen

871

Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives

872

Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy

873

Pharmacogenomic Profiling of the PI3K/PTEN Pathway in Sporadic Breast Cancer

874

Pharmacogenomics and -genetics in colorectal cancer

875

Pharmacogenomics and the Failing Heart: Are We Waiting for Godot?

876

Pharmacogenomics for Infectious Diseases

877

pharmacogenomics implementation and hurdles to overcome; in the context of a developing country

878

Pharmacogenomics in bladder cancer

879

Pharmacogenomics in bladder cancer

880

Pharmacogenomics in Cancer Chemotherapy

881

Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone

882

Pharmacogenomics in non-small-cell lung cancer chemotherapy

883

Pharmacogenomics of organic anion-transporting polypeptides (OATP)

884

Pharmacogenomics- The Promise of Personalized Medicine

885

Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

886

Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

887

Pharmacogenomics: out of the lab and into the community

888

Pharmacognostic and Acute Toxicity Study of Burkea Africana Root

889

Pharmacognostic and AntiInflammatory Properties of Securigera securidaca Seeds and Seed Oil

890

Pharmacognostic and Elemental Analysis of the Leaves of Tapinanthus globifer (A. Rich). Tiegh

891

Pharmacognostic and Physico-chemical Investigation of Barleria cristata Linn. (Leaf) for Quality Control Assessment

892

Pharmacognostic and phytochemical investigation of Heracleum persicum Desf. ex Fischer

893

Pharmacognostic and Preliminary Phytochemical Investigation on Doronicum scorpioides Roots

894

Pharmacognostic Characteristics and Mutagenic Studies of Alstonia boonei De Wild

895

Pharmacognostic Characteristics of Hibiscus sabdariffa L. as a Means of Monitoring Quality

896

Pharmacognostic evaluation and physico-chemical analysis of Lantana camara (Linn.) flowers

897

Pharmacognostic evaluation of Achyranthes coynei: Leaf

898

Pharmacognostic Evaluation of Maesobotrya barteri (Baill) Hutch and Maesobotrya dusenii Pax (Euphorbiaceae) Leaves

899

Pharmacognostic Evaluation of Oxalis pes-caprae L. (Family Oxalidaceae)

900

Pharmacognostic evaluation of the leaves of Mitracarpus scaber Zucc (Rubiaceae)

901

Pharmacognostic Evaluation of the Leaves of Secamone afzelii (Schult) K Schum (Asclepiadaceae)

902

Pharmacognostic Investigation of the Leaves and Stems of Viburnum erubescens Wall.ex DC

903

Pharmacognostic Profile and Screening of Anti-Proliferative Potential of Methanolic Extract of Tripterygium wilfordii Plant on WRL-68 Cell Line and Function of Polycystin‐1

904

Pharmacognostic Standardization and Chromatographic Fingerprint Analysis on Triterpenoidal Constituents of the Medicinally Important Plant Artocarpus heterophyllus by High‑Performance Thin Layer Chromatography Technique

905

Pharmacognostic study of Argyreia pilosa stem

906

Pharmacognostic, Physicochemical and Phytochemical Investigations on Aerial Parts of Argemone mexicana L.

907

Pharmacognostical and physico-chemical evaluations of Cardiospermum halicacabum L. seeds

908

Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease

909

Pharmacognostical study of Chorisia insignis HBK. grown in Egypt

910

Pharmacognostical, physico-chemical and contamination studies of polyherbal formulation “qurse pudina”

911

Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse

912

Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice

913

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

914

Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging

915

Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers

916

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

917

Pharmacokinetic and drug interaction studies of Pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan

918

Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC–MS/MS after oral administration of the Swertia pseudochinensis extract

919

Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques, ,

920

Pharmacokinetic and Hemodynamic Responses to Oral Sildenafil During Invasive Testing in Children With Pulmonary Hypertension

921

Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats

922

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part 1. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

923

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Doseproportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers

924

Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension

925

Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida

926

Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats

927

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation

928

Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article.

929

Pharmacokinetic and tissue distribution of doxycycline in broiler chickens pretreated with either: Diclazuril or halofuginone

930

Pharmacokinetic and toxicological data of spirolides after oral and intraperitoneal administration

931

Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative

932

Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats

933

Pharmacokinetic application of fuzzy structure identification and reasoning

934

Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats

935

Pharmacokinetic behavior of marbofloxacin after intravenous, subcutaneous and intramuscular administrations in llamas (Lama glama)

936

Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population

937

Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury

938

Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration

939

Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration

940

Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs

941

Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: Simultaneous determination of ten active constituents by HPLC–MS/MS

942

Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica

943

Pharmacokinetic Computer Simulations of the Relationship Between In Vivo and In Vitro Neuroreceptor Subtype Selectivity of Radioligands

944

Pharmacokinetic considerations for targeted drug delivery

945

Pharmacokinetic differences between ethnic groups

946

Pharmacokinetic differences between ethnic groups

947

Pharmacokinetic dosing of aminoglycosides: a controlled trial

948

Pharmacokinetic Drug Food Interaction Study of Nateglinide and Pomegranate Fruit Juice

949

Pharmacokinetic drug‑drug interaction and their implication in clinical management

950

Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia

951

Pharmacokinetic enhancement of marbofloxacin by alpha-1-monolaurin pre-treatment in broiler chickens

952

PHARMACOKINETIC EVALUATION OF CLARITHROMYCIN ORAL CONTROLLED RELEASE MATRIX TABLETS FOR DESIRED BIOAVAILABILITY AND IMPROVED PATIENT COMPLIANCE

953

Pharmacokinetic evaluation of dipfluzine and its three metabolites in rat plasma using liquid chromatography–mass spectrometry

954

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

955

Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study

956

Pharmacokinetic Evaluation of Two Doses of Aminophylline/Theophylline Administered as Multiple Intermittent Infusions to Iranian Apneic Premature Neonates

957

Pharmacokinetic Interaction of Salbutamol Coadministered with Vasicine Isolated from Adhathoda vasica on Rabbit

958

Pharmacokinetic Interaction Study for Simvastatin and Parsley and Its Plasma Quantification Using LC-MS: A Focus on Drug Metabolic Enzymes

959

Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda

960

Pharmacokinetic Interactions between Intravenous Ciprofloxacin and Oral Ferrous Sulfate

961

Pharmacokinetic interactions: The effects of selected herbal extracts on permeation of P-glycoprotein substrate drugs across excised pig intestinal tissue

962

Pharmacokinetic Investigation to Study the In Vivo Bioavailability of Thiolated Chitosan Based Repaglinide Buccal Tablets

963

Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery

964

Pharmacokinetic model of daily selenium intake from contaminated seafood in Taiwan

965

Pharmacokinetic model of dioxin and furan levels in adipose tissue from Sawmill work involving chlorophenate fungicides

966

Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis

967

Pharmacokinetic of sulfaclozine in broiler chickens

968

Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. implementation of P3 pyridine N-Oxides to deliver an orally bioavailable series containing P1 N-Benzylamides

969

Pharmacokinetic Parameters and OverResponsiveness of Iranian Population to Propranolol

970

Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol

971

Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI

972

Pharmacokinetic parameters of valproic acid and carbamazepine from routinely collected data: Influence of patient characteristics

973

Pharmacokinetic profile of a sustained-delivery system for physostigmine in rats

974

Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction

975

Pharmacokinetic Profile of Plasma Levobupivacaine Following Fascia Iliaca Compartment Block for Proximal Femoral Fracture in Older Patient

976

Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice

977

Pharmacokinetic Properties of a New Controlled-Release Formulation of Carvedilol

978

Pharmacokinetic studies and human absorbed dose estimation of 68Ga-(4 {[(bis (phosphonomethyl)) carbamoyl] methyl}-7,10-bis(carboxymethy l) -1,4,7,10-tetraazacyclododec-1-yl) acetic acid

979

Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice

980

Pharmacokinetic Studies of Enrofloxacin in Yak after Intramuscular Administration

981

Pharmacokinetic studies of metformin and glibenclamide in normal human volunteers

982

Pharmacokinetic studies of protein drugs: Past, present and future

983

Pharmacokinetic Studies of Rifampicin in Healthy Volunteers and Tuberculosis Patients

984

Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues

985

Pharmacokinetic Studies on Metoprolol - Eudragit Matrix Tablets and Bioequivalence Consideration with Mepressor®

986

Pharmacokinetic Studies on Oximes in Organophosphate Poisoning: A Mini Review

987

Pharmacokinetic Study of a Capsule-based Chronomodulated Drug Delivery System of Salbutamol Sulphate in Rabbits

988

Pharmacokinetic study of acyl-protected hydroxylamine probe, 1-acetoxy-3-carbamoyl-2,2,5,5-tetramethylpyrrolidine, for in vivo measurements of reactive oxygen species

989

Pharmacokinetic study of calenduloside E and its active metabolite oleanolic acid in beagle dog using liquid chromatography–tandem mass spectrometry

990

Pharmacokinetic study of carbamazepine and its carbamazepine 10,11-epoxide metabolite in a group of female epileptic patients under chronic treatment

991

PHARMACOKINETIC STUDY OF CEPHRADINE IN PAKISTANI HEALTHY MALE VOLUNTEERS

992

Pharmacokinetic study of dicloxacillin sodium following intravenous and intramuscular administration to pigs

993

Pharmacokinetic study of dl-tetrahydropalmatine patches by UPLC–MS/MS in rabbits

994

Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract

995

Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry

996

Pharmacokinetic study of furosemide incorporated PLGA microspheres after oral administration to rat

997

Pharmacokinetic study of HS061, a new human insulin, in non-diabetic rat using ultra performance liquid chromatography–tandem mass spectrometry

998

Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography

999

Pharmacokinetic study of mangiferin in human plasma after oral administration

1000

Pharmacokinetic study of melamine in rhesus monkey after a single oral administration of a tolerable daily intake dose

بازگشت